Source: Annual Congress 2009 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Quarck, T. Nawrot, B. Meyns, M. Delcroix (Leuven, Diepenbeek, Belgium). C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. Eur Respir J 2009; 34: Suppl. 53, 1887

Member's Comments

No comment yet.

Related content which might interest you: Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 939-944 Year: 2012 PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension Source: ERS Lung Science Conference 2021 Year: 2021 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 C-reactive protein levels in COPD according to clinical parameters, smoking behavior and pulmonary hypertension Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 912-914 Year: 2014 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015